NO20055725L - Glutamatreseptorantagonister som neurobeskyttende midler - Google Patents
Glutamatreseptorantagonister som neurobeskyttende midlerInfo
- Publication number
- NO20055725L NO20055725L NO20055725A NO20055725A NO20055725L NO 20055725 L NO20055725 L NO 20055725L NO 20055725 A NO20055725 A NO 20055725A NO 20055725 A NO20055725 A NO 20055725A NO 20055725 L NO20055725 L NO 20055725L
- Authority
- NO
- Norway
- Prior art keywords
- glutamate receptor
- receptor antagonists
- neuroprotective agents
- neuroprotective
- agents
- Prior art date
Links
- 239000004090 neuroprotective agent Substances 0.000 title abstract 2
- 239000003825 glutamate receptor antagonist Substances 0.000 title 1
- 102000018899 Glutamate Receptors Human genes 0.000 abstract 1
- 108010027915 Glutamate Receptors Proteins 0.000 abstract 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
- 102100033571 Tissue-type plasminogen activator Human genes 0.000 abstract 1
- 108050006955 Tissue-type plasminogen activator Proteins 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10337098 | 2003-05-05 | ||
| DE10320336 | 2003-05-06 | ||
| DE10352333 | 2003-11-06 | ||
| PCT/EP2004/004776 WO2004098635A1 (fr) | 2003-05-05 | 2004-05-05 | Antagonistes du recepteur de glutamate servant d'agents neuroprotecteurs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055725D0 NO20055725D0 (no) | 2005-12-02 |
| NO20055725L true NO20055725L (no) | 2005-12-02 |
Family
ID=33436868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055725A NO20055725L (no) | 2003-05-05 | 2005-12-02 | Glutamatreseptorantagonister som neurobeskyttende midler |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080213244A1 (fr) |
| EP (1) | EP1622640A1 (fr) |
| JP (1) | JP2006525277A (fr) |
| KR (1) | KR20060015721A (fr) |
| AU (1) | AU2004237407A1 (fr) |
| BR (1) | BRPI0410055A (fr) |
| CA (1) | CA2524342A1 (fr) |
| EA (1) | EA200501753A1 (fr) |
| HR (1) | HRP20050898A2 (fr) |
| MX (1) | MXPA05011762A (fr) |
| NO (1) | NO20055725L (fr) |
| WO (1) | WO2004098635A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10153601A1 (de) * | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
| US20080057050A1 (en) * | 2003-05-02 | 2008-03-06 | Paion Deutschland Gmbh | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
| KR20080027875A (ko) * | 2005-06-24 | 2008-03-28 | 빌렉스 아게 | 유로키나아제 억제제의 신경병리적 질병의 치료 및/또는예방을 위한 용도 |
| TWI482628B (zh) * | 2007-10-18 | 2015-05-01 | Lundbeck & Co As H | 新穎之血栓溶解病患次群 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5786187A (en) * | 1995-09-21 | 1998-07-28 | The Research Foundation Of State University Of New York | Method for reducing neuronal degeneration associated with seizure |
| DE10153601A1 (de) * | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
-
2004
- 2004-05-05 US US10/555,583 patent/US20080213244A1/en not_active Abandoned
- 2004-05-05 KR KR1020057021076A patent/KR20060015721A/ko not_active Withdrawn
- 2004-05-05 EP EP04731137A patent/EP1622640A1/fr not_active Withdrawn
- 2004-05-05 AU AU2004237407A patent/AU2004237407A1/en not_active Abandoned
- 2004-05-05 EA EA200501753A patent/EA200501753A1/ru unknown
- 2004-05-05 JP JP2006505376A patent/JP2006525277A/ja active Pending
- 2004-05-05 BR BRPI0410055-7A patent/BRPI0410055A/pt not_active IP Right Cessation
- 2004-05-05 MX MXPA05011762A patent/MXPA05011762A/es not_active Application Discontinuation
- 2004-05-05 CA CA002524342A patent/CA2524342A1/fr not_active Abandoned
- 2004-05-05 WO PCT/EP2004/004776 patent/WO2004098635A1/fr active Application Filing
-
2005
- 2005-10-14 HR HR20050898A patent/HRP20050898A2/xx not_active Application Discontinuation
- 2005-12-02 NO NO20055725A patent/NO20055725L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004098635A1 (fr) | 2004-11-18 |
| HRP20050898A2 (en) | 2007-03-31 |
| CA2524342A1 (fr) | 2004-11-18 |
| JP2006525277A (ja) | 2006-11-09 |
| BRPI0410055A (pt) | 2006-04-25 |
| EP1622640A1 (fr) | 2006-02-08 |
| AU2004237407A1 (en) | 2004-11-18 |
| NO20055725D0 (no) | 2005-12-02 |
| US20080213244A1 (en) | 2008-09-04 |
| KR20060015721A (ko) | 2006-02-20 |
| EA200501753A1 (ru) | 2006-04-28 |
| MXPA05011762A (es) | 2006-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
| RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
| DK1778236T3 (da) | Modificerede pyrimidin-glucocorticoid-receptor-modulatorer | |
| NO20061845L (no) | Fenyl-piperazinderivater som modulatorer for muskarine reseptorer | |
| EA200701790A1 (ru) | Твёрдый фармацевтический дозированный состав | |
| NO20034289D0 (no) | N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren | |
| TNSN07196A1 (en) | Potentiators of glutamate receptors | |
| ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
| NO20073244L (no) | Konjugeringsprodukt | |
| GEP20074078B (en) | Fluoro substituted cyclo-alkanoindoles, compositions comprising them and their use | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| NO20081160L (no) | Benzimidazoltiofen forbindelser | |
| DE602004012083D1 (de) | Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren | |
| CY1107368T1 (el) | Νεα παραγωγα 4-βενζυλιδενο-πιπεριδινης | |
| MEP15908A (en) | 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics | |
| NO20025136D0 (no) | Cykloheksylaminderivat som subtype selektive NMDA- reseptorantagonister | |
| NO20071922L (no) | Indazoler, benzisokazoler og benzinsotiazoler og anvendelse derav som ostrogene midler | |
| MY135916A (en) | Use of certain affinity nmda antagonists as antidepressants | |
| NO20075599L (no) | Profylaktisk eller terapeutisk middel mot depresjon eller angstforstyrrelser | |
| DE602004014772D1 (de) | Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| EA200600953A1 (ru) | Дозированные формы торсемида пролонгированного высвобождения | |
| NO20065905L (no) | Ny assosiasjon av en sinusknute If strominhibitor og en angiotensinkonvertaseinhibitor, og farmasoytiske sammensetninger inneholdende den | |
| NO20065903L (no) | Ny assosiasjon av en sinusknute If strominhibitor og en kalsiuminhibitor, og farmasoytiske sammensetninger inneholdende den | |
| NO20055725L (no) | Glutamatreseptorantagonister som neurobeskyttende midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |